Making Treatment Decisions with HIV Infection:

Abstract

The importance of understanding patient preferences in making treatment decisions is widely recognized. This pilot study utilized a forced-choice paired-comparison method in which 28 ambulatory HIV-infected patients were given a computer-generated presentation of all possible pairs of eight different treatment options for their disease (FDAapproved medications, experimental and alternative treatments, no medication). Preferences were analyzed using binary multidimensional scaling analyses to determine the utility of paired-comparison models for the study of treatment-decision making and to identify factors influencing patient decision making. Results indicated that a three-dimensional model provided the best fit for the data. One dimension correlated with medications that raise CD4+ lymphocyte counts (r = 0.92, p < 0.001) and a second dimension correlated with frequency of dosing (r = 0.97, p < 0.0001). Patients' internal consistency of decision making was inversely correlated with severity of AIDS dementia symptoms as measured by performance on a neuropsychological test battery (r = -0.55, p < 0.0025). This finding indicates that AIDS dementia may significantly hinder patients' ability to use a rational (internally consistent) decision-making strategy in making treatment choices. Results also suggested that AIDS patients base treatment decisions primarily on the likelihood of raising CD4+ cell counts and restrictiveness of dosing regimens, but are not influenced by FDA approval status, volume of empirical support for the medications, or even possible harmful side effects. The implications of these findings for the treatment of patients with AIDS are discussed. Key words: treatment decisions; patient preferences; HIV infection; AIDS; informed consent. (Med Decis Making 1997;17:307-314)

Get full access to this article

View all access options for this article.

References

Wills CE , Moore CF. Judgment processes for medication acceptance : self-reports and configural information use. Med Decis Making. 1994;14:137-45.

Rothert ML.

Physicians' and patients' judgments of compliance with a hypertensive regimen

Med Decis Making. 1982, 2:179-95.

Surber CF.

Measuring the importance of information in judgment: individual differences in weighting ability and effort

Organ Behav Hum Decis Proc. 1985;35:156-78

Nisbett NE , Wilson TD

Telling more than we can know verbal reports on mental processes

Psychol Rev. 1977,84:231-77.

Abelson RP , Levi A. Decision making and decision theory In Lindzey G , Aronson E (eds) The Handbook of Social Psychology 3rd ed New York: Random House, 1985,231-309

Ericcson KA , Simon HA

Verbal reports as data

Psychol Rev. 1980,87 215-51

Reilly BA , Doherty ME. A note on the assessment of self-insight in judgment research. Organ Behav Hum Decis Proc 1989,44:123-31.

Slovic P. The construction of preferences. Am Psychol 1995; 50:364-71

DeSarbo WS , Oliver RL , DeSoete G. A probabilistic multidimensional scaling vector model. Appl Psychol Meas. 1986;10 79-98.

10.

DeSarbo WS , deSoete G , Jedidi K Probabilistic multidimensional scaling models for analyzing consumer choice behavior. Communication and Cognition 1987 ;20:93-116

11.

Rosenfeld B , Turkheimer E.

Modeling psychiatric patients' treatment decision-making

Law Human Behav. 1995;19: 389-405.

12.

Abrams DI. Alternative therapies in HIV infection. AIDS. 1990; 4:1179-87.

13.

Clumeck N. Current use of anti-HIV drugs in AIDS. J Antimicrob Chemother 1993;32 suppl A.133-8.

14.

Torres G D4T side effects . Treatment Issues 1992;7:7.

15.

Nguyen BY , Shay LE , Wyvill KM , Pluda JM , Brawley O. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection. J Infect Dis. 1993; 168:810-7.

16.

Physicians Desk Reference 47th ed. Montvale, NJ Medical Economics, 1993.

17.

Hamilton M A rating scale for depression. J Neurol Neurosurg Psychiat. 1960;23:56-61

18.

Hamilton M The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-5.

19.

Lezak M. Neuropsychological Assessment. New York. Oxford University Press, 1983.

20.

Trites RL. Neuropsychological Test Manual Lafayette, IN: Lafayette Instrument Company, 1977.

21.

21 Halstead WC Brain and Intelligence, Chicago, IL: University Press, 1947

22.

Tancredi LR. The mental status exam. Generalist 1987;11: 24-31

23.

Lunn S , Skydsbjerg M , Schulsinger H , et al. A preliminary report on the neuropsychological sequelae of human immunodeficiency virus Arch Gen Psychiat 191;48:139-42.

24.

Price R , Sidtis JJ.

Evaluation of the AIDS dementia complex in clinical trials

J Acquired Immune Deficiency Syndromes. 1990;3(suppl 2):S51-S60

25.

Tross S , Price RW , Navia B , et al Neuropsychological characterization of AIDS dementia complex: a preliminary report. AIDS. 1988,2.81-8.

26.

McArthur JC , Selnes OA , Glass JD , Hoover DR , Bacellar H. HIV dementia. incidence and risk factors. In Price RW , and Perry SW (eds) HIV, AIDS, and the Brain New York Raven Press, 1994;251-72.

27.

Arabie P , Carroll JD , DeSarbo WS Three-way scaling and clustering. Sage University Paper series Quantitative Applications in the Social Sciences, #65 Newbury Park, CA: Sage Publications, 1987

28.

Rosenfeld BD , Turkheimer EN , Gardner WP

Decision making in a schizophrenic population

Law Hum Behav 1992;16: 651-62.

29.

Rosenfeld B , Turkheimer E.

Multidimensional representation of decision-making in chronic schizophrenics

Multivar Behav Res 1995,30:199-211

30.

DeSarbo WS , Howard DJ , Jedidi K. MULTICLUS: a new method for simultaneously performing multidimensional scaling and cluster analyses. Psychometrika. 1991,56:121-36.